BioAxone Biosciences Inc. is a biotechnology company with a focus on regenerative medicine for unmet medical needs. The company specializes in the development and commercialization of proprietary medicines targeting Rho signaling, a key target pathway for treating neurotrauma and neurological disease. Specifically, the company's technology has applications in cerebral vascular disorders, glaucoma, and spinal cord injuries. The company is pursuing an aggressive and focused strategy to treat spinal cord injury centered around the biologic therapeutic Cethrin. The firm's primary product, Cethrin, was designed to help injured nerve cells in the spinal cord regenerate and rebuild the connections necessary for body control. Cethrin was named a Top Ten Neurosciences Project to Watch by Windhover and featured in Nature as one of the treatments with the potential to become "handy implements in the neurosurgeon's kit.â
